Li Jing, Wang Peng, Zhang Cuiping, Leng Junhong, Li Nan, Wang Leishen, Li Wei, Liu Huikun, Yu Zhijie, Hu Gang, Chan Juliana C N, Yang Xilin
Department of Epidemiology and Biostatistics, School of Public Health & National Demonstration Center for Experimental Preventive Medicine Education, Tianjin Medical University, Tianjin, China.
Tianjin Women and Children's Health Center, Tianjin, China.
Front Endocrinol (Lausanne). 2018 Jun 26;9:349. doi: 10.3389/fendo.2018.00349. eCollection 2018.
Short height is associated with gestational diabetes mellitus (GDM) but the underlying mechanism remains unknown. This study aims to explore whether short height has a synergistic effect with pre-pregnancy overweight/obesity and undue weight gain on the risk of GDM. We recruited 19,962 singleton pregnant women from their first antenatal care visit in urban Tianjin, China, between October 2010 to August 2012. At 24-28 weeks of gestation, women underwent a 50-g 1-h glucose challenge test (GCT) followed by a 75-g 2-h oral glucose tolerance test (OGTT) if the GCT result was ≥7.8 mmol/L. GDM was defined by the International Association of Diabetes and Pregnancy Study Group's cut-points. Univariable and multivariable logistic regression analyses were performed to obtain odds ratios (ORs) and 95% confidence intervals (CIs). Restricted cubic spline (RCS) analysis nested in the logistic regression analysis was used to identify a cutoff point of height for GDM. Additive interaction was used to test interactions between short height, pregnancy overweight/obesity and undue weight gain. A total of 1,517 (or 7.6%) women developed GDM. The risk of GDM increased rapidly with a decreasing height from 158 cm and downwards. Using height ≥158 cm as the reference group, women with < 158 cm of height were at increased GDM risk (adjusted OR: 1.44, 95%CI: 1.18-1.75). Maternal overweight/obesity at the first antenatal care visit greatly enhanced the OR of short height for GDM (adjusted OR: 3.78, 95%CI: 2.84-5.03) with significant additive interaction ( < 0.05). However, the interaction between short height and undue weight gain was non-significant ( > 0.05). In Chinese pregnant women in urban Tianjin, height < 158 cm had a synergistic effect with pre-pregnancy overweight/obesity on the risk of GDM.
身材矮小与妊娠期糖尿病(GDM)相关,但潜在机制尚不清楚。本研究旨在探讨身材矮小是否与孕前超重/肥胖及孕期体重过度增加对GDM风险存在协同作用。2010年10月至2012年8月期间,我们在中国天津市区招募了19962名单胎孕妇,她们均为首次产前检查就诊。妊娠24 - 28周时,孕妇接受50g 1小时葡萄糖耐量试验(GCT),若GCT结果≥7.8 mmol/L,则随后进行75g 2小时口服葡萄糖耐量试验(OGTT)。GDM根据国际糖尿病与妊娠研究组的切点定义。进行单变量和多变量逻辑回归分析以获得比值比(OR)和95%置信区间(CI)。嵌套在逻辑回归分析中的限制立方样条(RCS)分析用于确定GDM的身高切点。采用相加交互作用检验身材矮小、孕期超重/肥胖与孕期体重过度增加之间的相互作用。共有1517名(或7.6%)妇女患GDM。GDM风险随着身高从158 cm及以下降低而迅速增加。以身高≥158 cm为参照组,身高< 158 cm的妇女患GDM风险增加(调整后OR:1.44,95%CI:1.18 - 1.75)。首次产前检查时孕妇超重/肥胖极大地增强了身材矮小导致GDM的OR(调整后OR:3.78,95%CI:2.84 - 5.03),且存在显著的相加交互作用(< 0.05)。然而,身材矮小与孕期体重过度增加之间的交互作用不显著(> 0.05)。在天津市区的中国孕妇中,身高< 158 cm与孕前超重/肥胖对GDM风险存在协同作用。